Latvia
Insider Sale: Chief Scientific Officer Stephen Betz Sells Shares of Crinetics Pharmaceuticals Inc (CRNX)
Chief Scientific Officer Stephen Betz sold 3,000 shares of Crinetics Pharmaceuticals Inc (CRNX) on July 25, 2024, as reported in a recent SEC Filing. Following